TABLE 3.
Gene name | Resistancea | Hypersusceptibilitya | % change for: |
||
---|---|---|---|---|---|
Ala-Nap effluxb,d | R-6G effluxb,d | R-6G efflux with FK506c,d | |||
abcA | POS, R-6G | — | +72 | +169 | −34 |
abcC | CLT, FLC, ITC, KTC, POS, R-6G, TEBZ, VRC | — | +158 | +175 | −61 |
abcF | CLT, ECON, FLC, ITC, KTC, MET, MCZ, PCLZ, POS, R-6G, TEBZ | AMB, CR, CW, NaCl | +121 | +223 | −51 |
abcG | — | — | +48 | +62 | −73 |
abcH | R-6G | CR | +35 | +29 | −99 |
abcI | FLC, R-6G | NaCl | +11 | +73 | 0 |
WT/PDR5 | CLT, FLC, ITC, KTC, MET, PCLZ, POS, R-6G, VRC | G418 | +35 | +356 | −82 |
As determined by MIC or spot assays to differ from the S. cerevisiae ΔPDR5 mutant by >4-fold. —, MIC or spot assay value does not significantly differ from the S. cerevisiae ΔPDR5 mutant value.
Percent increase of efflux compared to the S. cerevisiae ΔPDR5 mutant.
Percent decrease in R-6G efflux in the presence of FK506 and GLC compared to GLC-only.
Based on efflux rates from 0 to 20 min.